Symbols / ZGNX
ZGNX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest - Investor's Business Daily Wed, 19 Jan 2022 08
- UCB Completes Acquisition of Zogenix, Inc. - PR Newswire Mon, 07 Mar 2022 08
- Zogenix shares slip despite FDA nod for Dravet syndrome drug | 2020-06-26 - BioWorld MedTech Fri, 26 Jun 2020 07
- Zogenix (ZGNX) Stock Price, News & Analysis - MarketBeat Fri, 05 Jun 2015 03
- UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position - Fierce Pharma Wed, 19 Jan 2022 08
- Zogenix Announces Pricing of Initial Public Offering - NBC News Mon, 22 Nov 2010 08
- Can This Biotech Stock Rival The First FDA-Approved Cannabis Medicine? - Investor's Business Daily hu, 27 Jun 2019 07
- FDA approves tamper-resistant reformulation of Zohydro in continuing battle against opioid abuse - Fierce Pharma Wed, 04 Feb 2015 08
- GW Pharma Soars To Record High On Jazz's $7.2 Billion Takeover Deal - Investor's Business Daily Wed, 03 Feb 2021 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ZGNX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|